Remove 2026 Remove Enterprise Value Remove Finance Remove Marketability
article thumbnail

Orchestra BioMedâ„¢ Announces Strategic Collaboration, Closing of $110 Million Private Equity Financing and Plans to List on Nasdaq Through Merger with Health Sciences Acquisitions Corporation 2

Benzinga

Investors in $110 million Series D financing include Medtronic and Terumo as well as lead investor RTW Investments and founding investor Perceptive Advisors. The Series D financing was not contingent on the consummation of the Business Combination. NEW HOPE, Pa.

article thumbnail

Alamos Gold Announces Friendly Acquisition of Argonaut Gold

Benzinga

million common shares as part of the Transaction, representing an equity value of approximately US$276 million on a fully diluted in-the-money basis, and an enterprise value of US$516 million. This financing will allow Argonaut to fund its immediate liquidity needs related to its loan facilities and operations.